Trials / Unknown
UnknownNCT05860062
Vitamin D Supplementation in Episodic and Chronic Tension-type Headache
Evaluation of Vitamin D Supplementation in Patients With Episodic and Chronic Tension-type Headache.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn about the effect of vitamin D in patients with prophylactic therapy for episodic and chronic tension-type headache in amitriptyline or topiramate treatment. The main question it aims to answer are: • What is the effect of vitamin D in patients with prophylactic therapy for episodic and chronic tension-type headache? Patients will have the next selection criteria: * Patients diagnosed by a neurologist in the headache clinic * Criteria for episodic and chronic tension-type headache * Poor clinical response to prophylactic treatment (amitriptyline, topiramate) * Use of at least 1 prophylactic medication or a history of having used them. * Onset of disease between the ages of 18 and 60 * Signature of informed consent The population will be randomly divided into the following 3 treatment groups: * Participants amitriptyline or topiramate treatment. * Patients with placebo (Calcium) + topiramate/amitriptyline, * Participants with vitamin D3/calcium+topiramate/amitriptyline. Researchers will compare the groups to see if vitamin D can decrease the intensity of your headache and therefore have a new therapeutic option.
Detailed description
It will be a 4 month study. Each month a package containing treatment will be delivered, which may be conventional medication or tablets with conventional medication added with vitamins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D | Patients with prophylactic treatment (amitriptyline, topiramate) + 0.266 mg of calcifediol (15,960 IU of vitamin D) |
| OTHER | Calcium | 3: Patients with prophylactic treatment (amitriptyline, topiramate) + and Calcium: 1 Tablet every 24 hours containing: Calcium Carbonate 300 mg + Calcium Lactate Gluconate 2.94 g (500 mg of calcium). |
Timeline
- Start date
- 2023-04-18
- Primary completion
- 2023-09-20
- Completion
- 2023-12-20
- First posted
- 2023-05-16
- Last updated
- 2023-05-16
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT05860062. Inclusion in this directory is not an endorsement.